PFD-54869 |
MASON NATURAL GLUCOSAMINE CHONDROITIN 1500/1200 PLUS MSM 1000 Tabletas |
2023-01-23 |
|
Mason Vitamins Incorporated |
Estados Unidos de América
|
Vitamins Unlimited Intl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-54871 |
MASON NATURAL ECHINACEA 500 mg Cápsulas |
2023-01-24 |
|
Mason Vitamins Incorporated |
Estados Unidos de América
|
Vitamins Unlimited Intl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-55007 |
HEALTHY SENSE BODY, HAIR, SKIN & NAILS Cápsulas |
2023-03-08 |
|
Mason Vitamins Incorporated |
Estados Unidos de América
|
Vitamins Unlimited Intl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-55163 |
MASON NATURAL HEART TRIO: Co Q-10 VITAMIN E & FISH OIL Cápsulas de Gelatina Suave |
2023-04-09 |
|
Vitamins Unlimited Intl |
Estados Unidos de América
|
Vitamins Unlimited Intl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-55381 |
MASON NATURAL RELAX & SLEEP Tabletas recubiertas |
2023-06-18 |
|
Mason Vitamins Incorporated |
Estados Unidos de América
|
Vitamins Unlimited Intl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52490 |
METFORMINA HCL, Omni Health Solution, 1000 mg Tabletas de liberación Prolongada |
2021-02-12 |
|
Omni Health Solutions, LTD. |
Estados Unidos de América
|
Grupo Carinsa |
Omni Health Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-54353 |
ALFACALCIDOL Omni Health 1 mcg Cápsulas de gelatina suave |
2022-08-04 |
|
Omni Health Solutions, LTD. |
Estados Unidos de América
|
Grupo Carinsa |
Omni Health Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54819 |
CEFTRIAXONA Omni Health 1 g Polvo para inyección |
2023-01-11 |
|
Omni Health Solutions, LTD. |
Estados Unidos de América
|
Grupo Carinsa |
Omni Health Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-57204 |
INDAPAMIDA Omni Health 1.5 mg Tabletas recubiertas de liberación prolongada |
2024-09-12 |
|
Omni Health Solutions, LTD. |
Estados Unidos de América
|
Dispromed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-57206 |
RAMIPRIL Omni Health 5 mg Tabletas |
2024-09-12 |
|
Omni Health Solutions, LTD. |
Estados Unidos de América
|
Dispromed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|